外围T细胞淋巴瘤对构成性激活的JAK3的依赖:作为治疗方法,对JAK3抑制的含义
Kang Le1, Jordan Vollenweider1, JingJing Han2
1Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, George Washington University, GW Cancer Center, Washington, District of Columbia, USA.
简氏激酶-3 (JAK3) 是周围T细胞淋巴瘤 (PTCL) 的治疗点. 抑制JAK3,特别是与ALK向治疗相结合,通过阻断STAT3信号传递,显著降低了PTCL细胞存活率.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 周围T细胞淋巴瘤 (PTCL) 是一组多样化的淋巴瘤,治疗结果不佳.
- 简氏激酶 (JAK) 异型在PTCL细胞存活信号中的作用尚不清楚.
- 了解PTCL的分子驱动因素对于开发有效疗法至关重要.
研究的目的:
- 研究JAK异型,特别是JAK3在PTCL细胞信号传递和生存中的作用.
- 确定JAK3是否是PTCL中可行的治疗点.
- 探索将JAK3抑制剂与ALK向治疗相结合的潜力.
主要方法:
- 对PTCL瘤的免疫组织化学分析 (n=96) 以评估JAK3和STAT3激活.
- 在PTCL细胞中的JAK异型 (JAK1,JAK2,JAK3) 的药理抑制.
- 研究PTCL细胞中JAK3和ALK之间的相互作用.
- 评估JAK3和ALK抑制剂对PTCL细胞存活的联合疗效.
主要成果:
- 在PTCL瘤中发现了高水平的构成性活性JAK3 (pJAK3),与STAT3激活相关.
- 药理上抑制JAK3,但不抑制JAK1/JAK2,显著降低了PTCL增殖,存活率和STAT3激活.
- 与ALK阴性PTCL相比,ALK阳性PTCL中的JAK3激活显著更高.
- 发现JAK3和ALK在PTCL细胞中形成复合体,可能调节STAT3信号传递.
- 与单个药物相比,联合抑制JAK3和ALK显著降低了PTCL细胞存活率.
结论:
- JAK3具有构成性活性,在PTCL细胞生存信号传递中起着关键作用.
- JAK3是PTCL患者的一个子集的潜在治疗标.
- 与JAK3抑制剂和ALK向药物的联合治疗需要对PTCL治疗进行临床评估.
更多相关视频
07:12Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
Published on: September 9, 2021
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
相关概念视频
The JAK-STAT Signaling Pathway
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
PI3K/mTOR/AKT Signaling Pathway
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Non-Canonical Wnt Signaling Pathways
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
